PEOPLE - Oxis International makes appointment:
This article was originally published in Clinica
Portland, Oregon-based oxidative stress diagnostics firm Oxis International has named Dr Gosse Bruinsma as chairman of the board of directors, following the retirement of current chairman, CEO and president, Ray Rogers. Dr Bruinsma, currently a member of the board, will also assume the role of acting CEO until a permanent appointment is made. Dr Bruinsma is president and COO of Anonyx, the majority shareholder in Oxis.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.